Article | REF: P3340 V1

Chirality and drugs

Author: Serge KIRKIACHARIAN

Publication date: March 10, 2005, Review date: January 1, 2021 | Lire en français

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!

Automatically translated using artificial intelligence technology (Note that only the original version is binding) > find out more.

    A  |  A

    6. Chirality and Regulatory Affairs

    It would be tedious to give an exhaustive presentation of the directives governing the marketing of chiral drugs, which are specific to each country. Various meetings have been held on this subject, with the aim of reaching a general consensus wherever possible .

    Extensive documentation on chiral drugs is available for Europe ...

    You do not have access to this resource.

    Exclusive to subscribers. 97% yet to be discovered!

    You do not have access to this resource.
    Click here to request your free trial access!

    Already subscribed? Log in!


    The Ultimate Scientific and Technical Reference

    A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
    + More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
    From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

    This article is included in

    Drugs and pharmaceuticals

    This offer includes:

    Knowledge Base

    Updated and enriched with articles validated by our scientific committees

    Services

    A set of exclusive tools to complement the resources

    Practical Path

    Operational and didactic, to guarantee the acquisition of transversal skills

    Doc & Quiz

    Interactive articles with quizzes, for constructive reading

    Subscribe now!

    Ongoing reading
    Chirality and Regulatory Affairs